Effects of omega-3 supplements on prophylaxis of pediatric migraine
Phase 2
- Conditions
- migraine.migraine
- Registration Number
- IRCT2013092914809N1
- Lead Sponsor
- Vice Chancellor for Research and Technology, Hamedan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
1.children in 5-14 years old age 2.Having migraine headache based on International Headache Society Criteria 3.Having frequent or disabling headaches that prophylactic therapy indicated in them (one or more headache attack per week or, three or more headache attacks per month or, more than one school day lost per month)
Exclusion Criteria
1.Diagnosis changes each time during the study 2.Secondary headaches or other neurologic disorders 3.Not to use drugs correctly
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Monthly frequency of headache. Timepoint: Before and after three months of treatment. Method of measurement: Asking from patient.;Severity of headache. Timepoint: Before and after three months of treatment. Method of measurement: Asking from patient.;Pediatric Migraine Disability Grade (pedMIDAS). Timepoint: Before and after three months of treatment. Method of measurement: Asking from patient.;Clinical general impression. Timepoint: Before and after three months of treatment. Method of measurement: Asking from patient.
- Secondary Outcome Measures
Name Time Method Omega-3 side effects including gastrointestinal side effects and allergy. Timepoint: Monthly until three months of treatment. Method of measurement: Clinical exam and asking from patients.